Clinical Trial Update: Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. [Phase 4]

View source ↗

Summary

Pfizer-sponsored Phase 4 trial evaluating cardiac safety across smoking cessation medications in people with and without psychiatric disorders has completed; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychiatric Disorders
• Tobacco Use Disorder

Drugs mentioned

• Chantix/varenicline (varenicline)

Snippet

Sponsor: Pfizer | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED | Results posted: 2016-12-29